1. Home
  2. MLTX vs SGHC Comparison

MLTX vs SGHC Comparison

Compare MLTX & SGHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MoonLake Immunotherapeutics

MLTX

MoonLake Immunotherapeutics

HOLD

Current Price

$13.49

Market Cap

972.7M

Sector

Health Care

ML Signal

HOLD

SGHC

Super Group (SGHC) Limited

HOLD

Current Price

$11.99

Market Cap

5.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLTX
SGHC
Founded
2021
2020
Country
Switzerland
Guernsey
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Services-Misc. Amusement & Recreation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
972.7M
5.8B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MLTX
SGHC
Price
$13.49
$11.99
Analyst Decision
Buy
Strong Buy
Analyst Count
9
8
Target Price
$36.33
$16.00
AVG Volume (30 Days)
1.9M
2.5M
Earning Date
11-05-2025
11-03-2025
Dividend Yield
N/A
1.35%
EPS Growth
N/A
4925.62
EPS
N/A
0.45
Revenue
N/A
$2,342,912,011.00
Revenue This Year
N/A
$27.17
Revenue Next Year
N/A
$10.88
P/E Ratio
N/A
$26.25
Revenue Growth
N/A
34.94
52 Week Low
$5.95
$5.45
52 Week High
$62.75
$14.38

Technical Indicators

Market Signals
Indicator
MLTX
SGHC
Relative Strength Index (RSI) 46.84 56.38
Support Level $13.09 $11.21
Resistance Level $15.40 $12.06
Average True Range (ATR) 0.90 0.43
MACD -0.05 0.11
Stochastic Oscillator 32.63 92.75

Price Performance

Historical Comparison
MLTX
SGHC

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

About SGHC Super Group (SGHC) Limited

Super Group (SGHC) Ltd is a holding company that operates online sports betting and gaming businesses. The company's reportable segments are Betway, Spin, and Other. A majority of its revenue is generated from the Betway segment, which is a single-brand online sports betting and casino offering with licenses to operate throughout Europe, the Americas, and Africa. Spin is the company's multi-brand online casino offering, having a diverse portfolio of casino brands such as Jackpot City, Spin Casino, Dream Bingo, Mirror Bingo, etc., designed to be culturally relevant globally while aiming to offer a wide range of casino products. Geographically, the company generates maximum revenue from Africa and Middle East, followed by North America, Europe, Asia-Pacific, and South/Latin America.

Share on Social Networks: